NCR2 and cancer: Feeder cells consisting of K562 expressing 4-1BBL and membrane-bound IL-15 have been used to expand NK cells for adoptive cell therapy for cancer, inducing upregulation of TRAIL, NKp44 and 4-1BB [12, 26].